The current SOC in AL amyloidosis: dara-CyBorD & considerations for patients with relapsed disease Published 2023-09-08 Download video MP4 360p Recommendations 02:25 Low-intensity venetoclax-based salvage as a bridge to alloSCT in AML 03:25 Final analysis of CENTAURUS: daratumumab monotherapy for SMM 04:15 Jupiter Sextiles Saturn - Greater Ease, Certainty, Resources Coming Together 04:34 What Is the Future for CAR-T in Multiple Myeloma? 02:16 Correcting the function of mutated hemoglobin with gene therapy for SCD 02:35 Inflammatory biomarkers as predictors of CAR-T efficacy in MM 00:53 Should patients with smoldering myeloma be treated outside of the clinical trial setting? 01:28 CAR-T therapy in AML: why has there been a lack of success? 03:11 Genetic mutations as poor prognostic indicators of HCT in venetoclax-treated AML 02:31 ctDNA allows for the prediction of outcomes following liso-cel infusion in patients with LBCL 02:00 Optimizing HMA treatment in HR-MDS: azacitidine versus decitabine 01:45 Outcomes for MM patients who are TCE and BCMA-exposed are poor 00:32 The role of immunotherapy in smoldering myeloma 01:59 Sutimlimab in cold agglutinin disease: a post-hoc analysis of safety data from CARDINAL & CADENZA 03:53 Mutational Burden in Patients with Treatment-Naïve CLL 00:52 The role of transplantation for patients with MCL in the era of CAR-T therapy 18:56 Why I Take Hydroxyurea (for Sickle Cell Disease)– An Unpopular Opinion 24:59 Dr David Kuter How I treat ITP Presentation 01:24 Real-world outcomes of patients with BV and anti-PD-1 intolerant cHL: the impact of alloSCT & CAR-T Similar videos 1:32:12 Smilow Shares: AL Amyloidosis 23:29 MPE Masterclass 2021 | Immunotherapy in the treatment of myeloma and AL amyloidosis 23:23 Identifying and treating high-risk patients in 2023 46:28 Not All M-Spikes are Myeloma 1:02:14 February 10, 2023 | Post ASH CME Series 2022: Multiple Myeloma 34:36 Highlights from ASCO / EHA 2021: latest updates on myeloma 1:16:36 Highlights from the 2019 ASH Annual Meeting 1:52:56 Hemato-Oncology Update with Focus on CAR T Cells | AIG Hospitals 1:38:38 SWOG Fall 2023 Hybrid Group Meeting: Bone Marrow & Stem Cell Transplantation Committee 1:16:26 Darzalex (daratumumab) | Tita TV 48:00 Nueva era en el mieloma múltiple - consecuencias de la llegada de nuevos tratamientos More results